ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Sevre-Long 120 mg, Kapseln retard - 30 Kapsel(n)
53952046 Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch
Sevre-Long 120 mg, Kapseln retard30.01.1997
  30.01.1997
Morphine (N02AA01)31.01.2008
WHO-DDD 
01.01.30.30 Kapsel(n)
01.01.30. 
A+  
Yes 
IPCI
54.52Yes
    
10 %75.70
7680539520465SynthetikaA
1859032 
Composition
morphini sulfas pentahydricus 120 mg corresp. morphinum 90.25 mg, oleum vegetabile hydrogenatum, macrogolum 6000, talcum, magnesii stearas, Kapselhülle: E 132, E 172 (nigrum), E 172 (flavum), E 171, natrii laurilsulfas corresp. natrium 0.012 mg, gelatina, Drucktinte: lacca, E 172 (nigrum), propylenglycolum, pro capsula.
Packungsbestandteile
Delayed release capsules 
 
Active AgentDose
Morphine Sulfate Pentahydrate120 mg correspond Morphine 90.25 mg
BAG: Active AgentDose
 120 mg
 
Inactive agentsDoseadditional_information
   
   
  Kapselhülle
  color.
  color.
Gelatina  
  Drucktinte
Macrogol6000  
   
   
   
   
Propylenglycol  
Talcum  
 
Source
Data was imported : 02.09.2022 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home